FSPGX
Price
$41.93
Change
+$0.47 (+1.13%)
Updated
Jul 3 closing price
Net Assets
37.26B
VIGIX
Price
$227.55
Change
+$2.46 (+1.09%)
Updated
Jul 3 closing price
Net Assets
293.94B
Interact to see
Advertisement

FSPGX vs VIGIX

Header iconFSPGX vs VIGIX Comparison
Open Charts FSPGX vs VIGIXBanner chart's image
Fidelity Large Cap Growth Idx
Price$41.93
Change+$0.47 (+1.13%)
VolumeN/A
Net Assets37.26B
Vanguard Growth Index Institutional
Price$227.55
Change+$2.46 (+1.09%)
VolumeN/A
Net Assets293.94B
FSPGX vs VIGIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSPGX vs. VIGIX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSPGX is a StrongBuy and VIGIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGIX has more cash in the bank: 294B vs. FSPGX (37.3B). VIGIX pays higher dividends than FSPGX: VIGIX (0.45) vs FSPGX (0.35). FSPGX was incepted earlier than VIGIX: FSPGX (9 years) vs VIGIX (27 years). VIGIX (0.04) is less costly to investors than FSPGX (0.04). FSPGX is a more actively managed with annual turnover of: 15.00 vs. VIGIX (11.00). FSPGX has a lower initial minimum investment than VIGIX: FSPGX (0) vs VIGIX (5000000). VIGIX (15.43) and FSPGX (15.21) have marching annual gain over last year. FSPGX return over 5 years is better than : 122.79 vs. VIGIX (115.38).
FSPGXVIGIXFSPGX / VIGIX
Total Expense Ratio0.040.0488%
Annual Report Gross Expense Ratio0.040.0488%
Fund Existence9 years27 years-
Gain YTD7.0467.72691%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets37.3B294B13%
Annual Yield % from dividends0.350.4577%
Returns for 1 year15.2115.4399%
Returns for 3 years98.6196.42102%
Returns for 5 years122.79115.38106%
Returns for 10 yearsN/A312.91-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IKT1.890.04
+2.16%
Inhibikase Therapeutics
ASX10.370.07
+0.68%
ASE Technology Holding Co Ltd
HTLD9.130.06
+0.66%
Heartland Express
QDEL30.190.01
+0.03%
QuidelOrtho Corp
ADN2.03-0.05
-2.36%
Advent Technologies Holdings Inc.